Skip to main content
Galapagos NV logo

Galapagos NV — Investor Relations & Filings

Ticker · GLPG ISIN · BE0003818359 LEI · 549300QKJ78IY0IOV655 BR Manufacturing
Open in API
Filings indexed 2,855 across all filing types
Latest filing 2025-10-21 Capital/Financing Update
Country BE Belgium
Listing BR GLPG

About Galapagos NV

https://www.glpg.com/

Galapagos NV is a biotechnology company focused on transforming patient outcomes through scientific innovation. The company is strategically concentrating its efforts on its cell therapy platform, which is engineered for the scalable, decentralized, and rapid production of next-generation treatments. A key feature of this platform is a median 7-day vein-to-vein delivery time. In parallel with this focus, Galapagos is actively seeking partners to take over its portfolio of small molecule assets, including its TYK2 inhibitor program for autoimmune indications. This strategic shift allows the company to prioritize the growth and development of its cell therapy pipeline through internal discovery, partnerships, and acquisitions.

Recent filings

Filing Released Lang Actions
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation
Capital/Financing Update Classification · 95% confidence The document is a press release issued by Galapagos NV announcing a significant strategic decision to wind down its cell therapy business. It details the rationale, the impact on employees and sites, the financial implications (estimated costs), and the involvement of legal and financial advisors. It is not a periodic financial report, a transcript, or a proxy statement. As it is a formal corporate announcement regarding a major business transformation and strategic shift, it falls under the category of general regulatory announcements/filings.
2025-10-21 English
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation.pdf
Regulatory Filings Classification · 100% confidence The document is a press release issued by Galapagos NV announcing a significant strategic decision to wind down its cell therapy business. It details the rationale, the impact on employees and sites, the financial implications (estimated costs), and the involvement of legal and financial advisors. It is not a periodic financial report, a transcript, or a proxy statement. As it is a formal corporate announcement regarding a major business transformation and strategic shift, it falls under the category of general regulatory announcements/filings.
2025-10-21 English
Galapagos kondigt intentie aan om celtherapieactiviteiten af te bouwen als onderdeel van de voortdurende transformatie van het bedrijf.pdf
Regulatory Filings Classification · 100% confidence The document is a press release from Galapagos NV announcing a significant strategic shift: the intention to wind down its cell therapy operations. It includes details on the rationale, financial impact, potential job losses, and the involvement of legal and financial advisors. It is a corporate announcement regarding business strategy and restructuring, which falls under the 'Regulatory Filings' (RNS) category as it is a formal announcement of material information to the market.
2025-10-21 Dutch
6-K Filing
Regulatory Filings
2025-10-21 English
Galapagos Announces Appointment of Fred Blakeslee as General Counsel
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new General Counsel (Fred Blakeslee) and the departure of the previous one (Valeria Cnossen). This falls directly under the category of changes in senior management.
2025-10-17 Dutch
Galapagos Announces Appointment of Fred Blakeslee as General Counsel
Board/Management Information Classification · 100% confidence The document is a press release announcing the appointment of a new General Counsel (Fred Blakeslee) at Galapagos NV. This falls under the category of management changes, which is explicitly defined as 'Board/Management Information' (MANG).
2025-10-17 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.